Premium
PROMIS ® scores in operative metastatic bone disease patients: A multicenter, prospective study
Author(s) -
Blank Alan T.,
Lerman Daniel M.,
Shaw Sara,
Dadrass Farnaz,
Zhang Yue,
Liu Wei,
Hung Man,
Jones Kevin B.,
Randall R. Lor
Publication year - 2018
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.25159
Subject(s) - medicine , patient reported outcomes measurement information system , demographics , prospective cohort study , physical therapy , population , surgery , computerized adaptive testing , psychometrics , clinical psychology , demography , environmental health , sociology
Background The prevalence of metastatic bone disease (MBD) grows each year as treatments improve. Little has been published about functional and pain outcomes in this group after surgery. Patient‐Reported Outcomes Measurement Information System (PROMIS ® ) can collect information, in just minutes, about patient's physical, mental, and social health. This study evaluated PROMIS ® pain and functional scores in surgically treated patients with MBD. Methods Basic demographics and PROMIS ® scores were recorded from a total of 13 patients at 9 periods of time over 6 months. Results The average change in physical function at week 1 was −2.5 (standard deviation [SD] = 5.4), at 2 weeks 1.7 (SD = 7.6), after 4 weeks 6.9 (SD = 10), after 6 weeks 6.4 (SD = 10.9), after 10 weeks 15.3 (SD = 3.1), and after 3 months 8.6 (SD = 7.6). The average change in pain inference at week 1 was −1.2 (SD = 7.3), at 2 weeks −2.1 (SD = 9.5), after 4 weeks −12.6 (SD = 4.5), after 6 weeks −8.3 (SD = 10.2), after 10 weeks −16.6 (SD = 4.3), and after 3 months −11.4 (SD = 8.2). Conclusions PROMIS ® provides a feasible means to collect data in this population. Trends of improved function and decreased pain were seen after surgery. Continuing this study will hopefully elucidate more insight into the surgical treatment of MBD.